TY - JOUR
T1 - Incentives for smoking cessation during pregnancy
T2 - an ethical framework
AU - Breunis, Leonieke J
AU - Been, Jasper V
AU - de Jong-Potjer, Lieke
AU - Steegers, Eric A P
AU - de Beaufort, Inez D
AU - de Kroon, Marlou L A
AU - Ismaili M'hamdi, Hafez
N1 - © The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - INTRODUCTION: Smoking during pregnancy increases the risk of morbidity and mortality of the mother and child. The inability of the unborn child to protect itself, raises the social and academic responsibility to protect the child from the harmful effects of smoking. Interventions including rewards ('incentives') for lifestyle changes are an upcoming trend and can encourage women to quit smoking. However, these incentives can, as we will argue, also have negative consequences, for example the restriction of personal autonomy and encouragement of smoking to become eligible for participation. To prevent these negative consequences, we developed an ethical framework that enables to assess and address unwanted consequences of incentive-based interventions whereby moral permissibility can be evaluated.METHODS: The possible adverse consequences of incentives were identified through an extensive literature search. Subsequently, we developed ethical criteria to identify these consequences based on the biomedical ethical principles of Beauchamp and Childress.RESULTS: Our framework consists of twelve criteria. These criteria concern (i) effectiveness, (ii) support of a healthy lifestyle, (iii) motivational for the target population, (iv) stimulating unhealthy behaviour, (v) negative attitudes, (vi) personal autonomy, (vii) intrinsic motivation, (viii) privacy, (ix) fairness, (x) allocation of incentives, (xi) cost-effectiveness, and (xii) health inequity. Based on these criteria, the moral permissibility of potential interventions can be evaluated.CONCLUSION: Incentives for smoking cessation are a response to the responsibility to protect the unborn child. But these interventions might have possible adverse effects. This ethical framework aims to identify and address ethical pitfalls in order to avoid these adverse effects.
AB - INTRODUCTION: Smoking during pregnancy increases the risk of morbidity and mortality of the mother and child. The inability of the unborn child to protect itself, raises the social and academic responsibility to protect the child from the harmful effects of smoking. Interventions including rewards ('incentives') for lifestyle changes are an upcoming trend and can encourage women to quit smoking. However, these incentives can, as we will argue, also have negative consequences, for example the restriction of personal autonomy and encouragement of smoking to become eligible for participation. To prevent these negative consequences, we developed an ethical framework that enables to assess and address unwanted consequences of incentive-based interventions whereby moral permissibility can be evaluated.METHODS: The possible adverse consequences of incentives were identified through an extensive literature search. Subsequently, we developed ethical criteria to identify these consequences based on the biomedical ethical principles of Beauchamp and Childress.RESULTS: Our framework consists of twelve criteria. These criteria concern (i) effectiveness, (ii) support of a healthy lifestyle, (iii) motivational for the target population, (iv) stimulating unhealthy behaviour, (v) negative attitudes, (vi) personal autonomy, (vii) intrinsic motivation, (viii) privacy, (ix) fairness, (x) allocation of incentives, (xi) cost-effectiveness, and (xii) health inequity. Based on these criteria, the moral permissibility of potential interventions can be evaluated.CONCLUSION: Incentives for smoking cessation are a response to the responsibility to protect the unborn child. But these interventions might have possible adverse effects. This ethical framework aims to identify and address ethical pitfalls in order to avoid these adverse effects.
U2 - 10.1093/ntr/ntz231
DO - 10.1093/ntr/ntz231
M3 - Article
C2 - 31848622
SN - 1462-2203
VL - 22
SP - 1553
EP - 1559
JO - Nicotine & Tobacco Research
JF - Nicotine & Tobacco Research
IS - 9
ER -